Available online on 15.02.2022 at http://jddtonline.info

Journal of Drug Delivery and Therapeutics

Open Access to Pharmaceutical and Medical Research

Copyright  © 2022 The  Author(s): This is an open-access article distributed under the terms of the CC BY-NC 4.0 which permits unrestricted use, distribution, and reproduction in any medium for non-commercial use provided the original author and source are credited

Open Access  Full Text Article                                                                                                                                                    Review Article 

Pharmaceutical Process Validation: A Review

C. Karthick¹*, K. Kathiresan ²

¹ PG Student, Department of Pharmacy, Annamalai University, Chidambaram, Tamil Nadu, India

² Associate Professor, Department of Pharmacy, Annamalai University, Chidambaram, Tamil Nadu, India

1. INTRODUCTION:

Process validation is vital parameter of CGMPs. To maintain Quality system regulation, Process validation is deliberately needed. The process validation is normalization of Verification documents to be submitted with the file for marketing authorization. It is planned to aid pharma producers in knowing quality management system (QMS) needs related to PV &  give appropriateness to pharmaceutical production cycle. As indicated by FDA, confirmation of product quality is gotten from cautious & fundamental look regarding various significant factors include: Determination of quality measures using in-process & finished goods testing. The verification is based on FDA regulations outlining the current cGMP in the pharmaceutical industry. 

The cGMP guidelines want that production processes are planned and controlled to guarantee that the in-process materials and the completed results fill prerequisites. Validation is thus the component of drug quality confirmation for process, the interaction shifts broadly; FDA and EC have developed common and non-compulsory guidelines. At that point validation implies, assessing validity or activity of demonstrating validity.  Process controls cover crude materials, in measure controls. The intention is to screen line activities of the production process & for approval. After this, process is validated and assuring elegantly composed methodology for the cycle controls and is favoured for its presentation..

2. NEED OF PROCESS VALIDATION:

FDA GUIDELINES:

The FDA finds rules & says “Process validation is setting up documented proof which gives high level of assurance that a particular process will reliably deliver a product meeting its foreordained details and quality attributes".

 For detailed studying and controlling of each and every procedure such as manufacturing, quality checking. Table 1 shows the checklist of PV.

Table 1: Checklist 

For existence of Safety, Quality, Efficacy¹ in product.  A validated process gives High degree of pledge for uniformity. Process validation does not improve anything related to quality of the product, but control and maintain the measures to fulfil requirements consistently through adequate validations.

3. BASICS PRINCIPLES OF VALIDATION:

3.1 Installation qualifications:  Start with proof that all aspects of the equipment and Installation comply with the accepted² specification.

IQ considerations are: 

●Equipment configuration highlights  

●Installation provisions (wiring)

● Measures, precautions to be taken, cleaning plans.

●Safety features.

●Supplier documentation, manuals etc

●Spare parts list.

●Environmental prospects just like clean facilities, humidity.

3.2 Operational Qualification (OQ): It gives highest confirmation that equipment functions as planned & qualifications.

OQ considerations are:

●Control limits (time, line speed)

●Raw material specifications. Handling³ requirements, Training, Short term stability & potential (studies or charts).

 ● Possible failure modes & worst-case.

3.3 Process Performance Qualification (PQ): It confirms the framework is reproducible & reliably create well product. They guarantee, by fitting execution records & documentation, that equipment, auxiliary & sub-systems authorized effectively.  The final reports should lie within limits.

PQ considerations are:

● Actual product and process boundaries setups

● Correctness of the product.

● Assurance of process capability, setups

● Process repeatability, long haul measures strength.

3.4 Re – Qualification: Qualification of appliance must obey assessments & approval of document that alters scheme, by modifying standard policies. This ritual analysis includes⁴ reflection of re-approval of equipment. Slight changes have no immediate impact on last or in-measure item quality should be taken care off by the documentation.

 4. PHASES IN VALIDATION:

 Phase-1:

This is pre-validation capability stage covers all works identified with product work, definition pilot group examines, scale-up examinations, move of innovation, building up wellness of control & capacity, operational capability and cycle limit⁵.

Phase-2:

It verifies all the limits of important process parameters are valid so that correct product shall be produced. 

Phase-3:

This is preservation phase, demands optimum review of documents link to process includes validations and report to confirm there are no changes deviations and failures, all of Standard Operating Procedures. It assumes that all the production and its control, works are conducted accordingly (GMP)

The validation steps advised⁶:

1. As a pre-essential, investigations ought to be directed as per a nitty gritty, pre-set up convention or arrangement of conventions, which thus is dependent upon formal – change control strategies 

2. Both the work force manages examinations & those running the process considered & be prepared, qualified, be reasonable & capable to play

3. Information produced upon the studies have to be officially investigated & ensured as thought about in contrast to pre-decided models 

4. Appropriate testing offices, hardware, instruments and philosophy ought to be accessible 

5. Reasonable tidy up room offices ought to be accessible in both “neighbourhood” and foundation climate. There ought to be affirmation that the tidy up room climate as indicated is gotten through beginning dispatching (capability) and in-measure equipment appropriately be introduced, qualified & kept up.

6. At the point when proper consideration has been paid to the abovementioned, the cycle, if aseptic, might be approved by methods for "measure recreation" contemplates 

7. The interaction ought to be revalidated at intervals.

8. Extensive documents have to be accessible for approval. 

5. TYPES OF VALIDATION:

5.1 Analytical validation:

It is the procedure agreed by laboratory studies. Validation of analytical methods is vital, time consuming. In growing laboratories. The analysis process was validated because these are regulatory requirements, good scientific and quality control⁷ requirements.  The CFR states that its accuracy, specificity and review of the procedures conducted by this organization must be established and documented. Methods should be validated when: 

>> It is of routine use. 

>> Change in conditions, changes the procedure 

>> Identifying new method with respect to standard.

 5.2 Cleaning validation:

It is an important process to assure complete removing of remaining part from manufacturing instruments. Cleaning validation simply validates cleaning procedures.

The reasons are:

1. Need of customer

2. Purity assuring 

3. This is a regular requirement in the API for product production 

4. Pharma products & API are pompous to pharmaceuticals & microbial contamination 

CV confirms⁸ Effectiveness of the cleaning process for the removal of product residues, decay products, and additives.  

5.3 Equipment Verification: 

The verification of equipment is called eligibility.  Equipment verification is divided into DQ, IQ, OQ & PQ. A DQ document mark regulatory conformity & picking logic of each supplier. An IQ documents mark things to verify installation is obvious and meet specifications. Reports are checked. 

5.4 Process validation:

It is a documented programme gives higher pledge that the process shall give results in a correct manner. The strategy is simple & straight forward. The accompanying components are introduced for our thought⁹:

1. The use of bunches of segments is to be included, e.g.: APIs & excipients

2. Batches ought to work in progression & on various days & movements 

3. Batches ought to be produced in equipment’s and increases trade production.

4. Important Process factors must be set within their function reaches and their limits should not surpass during measure activity.

5.4.1 Prospective validation:

It is performed to affirm that system works as said in agreement made previously and performed from start to distribution, at least for 3 batches (successive). The formalized validation program ought to never be embraced except if & until¹⁰ the accompanying activities and methodology have been finished agreeably: 

1. The provisions & appliances in which the approval is directed to fill CGMP necessities (finish of establishment requisite) 

2. The administrators & administering faculty doing the validation, understood the process & its necessities 

3. The plan, determination & streamlining of the formula are finished.

4. The capacity preliminaries utilizing (10 × size) pilot-research groups are finished, in which the basic preparation factors have been recognized, & the temporary operational control limits for each basic test boundary been given 

5. Complete specialized data on the product & the production cycle are given, also recorded proof of item dependability.

5.4.2 Retrospective Validation:

It is clarified as acknowledged archived evidence that framework does what it professes to do dependent on assessment and investigation of chronicled information done By survey of recorded assembling testing information to show that the process work as we want. The review approval choice is picked for accepted products whose manufacturing measures are viewed as steady and when based on financial contemplations alone and asset limits. The reason¹¹ for review approval is expressed in CFR: "Substantial in-measure determinations for such qualities will be predictable with drug products final statements and will be obtained from past trusted process mean and process changeability determines where conceivable and controlled by the use of appropriate factual strategies where proper." 

Retrospective validation may be carried as follows:

1. Collect mathematical Includes information measurements, final test results and process information from the completed batch record. 

2. Group details in an ordered manner as per batches producing information, utilizing a spreadsheet design

3. Information should be incorporated from in any event the past 20 to 30 produced bulks for examination. If the quantity is under 20, subsume every single produced batch.

4. Cut the information by disposing of test results of noncritical handling steps & erase unnecessary mathematical data. 

5. Put the resultant information to measurable investigation & assessment.

5.4.3 Concurrent Validation: 

CV varies from¹² prospective in one aspect that the operating firm in quality race sell the product to public at market rate. In process observing of processing and testing is required, performed when change or renewal in plant, site location. CV Documents are kept in RV. 

Table 2 shows various modes of CV.

Table 2: Concurrent validation modes

5.4.4 Revalidation¹³:

It completes when a change in batch size & successive batches never link product & process stipulations. It tends to prove changes in process or its environment not affect the process and product features . Documentation follows following initial plans:

Conditions requiring revalidation are:

1. Change in a critical segment (crude materials)

2. Change or substitution in a critical part of modular equipment

3. Change in a provision as well as plant (area or site)

4. Critical (significant degree) increment or abatement in size

5. Successive batches neglect to fill particulars

6. STAGES OF PROCESS VALIDATION:

PV confirms that process delivers quality product constantly. It takes several rows of actions such as followings:

6.1 Stage 1(Process Design)¹⁴: 

“Fully focused on competent endeavours without understanding the production process expands the information gained through the twists and turns of events and scale exercises at this stage. It understands all activities related to research and development, scale-up courses, technology change, business scale modules, pilot module studies, adoption of stability conditions, storage and handling of processed and finished product, EQ, IQ, Master production documents, working standards and process capability. Figure 1 is the chart for change in source of API.

6.2 Stage 2(Process Qualification):

 The action design is determined to determine the effective weather conditions for breeding commercial production. It recognizes that all accepted limits of critical parameters are valid and that too must be a satisfactory product and can be delivered under the worst conditions.  The rules of GMP acceptance must be followed, at a certain point and the successful completion of this stage is important before any commercial distribution of the product.

Figure 2: shows chart for control in manufacturing variables.

Figure 3 shows chart for change in batch size of product.

Figure 1: Decision chart for change in source of Active Pharmaceutical Ingredient

Figure 2:  Process validation chart for change in manufacturing variables control

Figure 3: Decision chart for change in batch size of product

6.3 Stage 3 – Continued Process Verification¹⁵:

Current guarantee is obtained during the process of being in standard form. Documents required for periodic repair phase verification should be reviewed frequently, as well as verification audit reports to ensure that no changes & deviation. An effective verification program relies on knowledge, understanding and an approach to controlling industrial processes.  These include the source of the variance, the extent to which the variance can be detected, and the properties responsible for the variance. Figure 4 shows the decision chart for change in equipment.

Figure 4: Decision chart for change in equipment

7. ACCEPTANCE CRITERIA AND INFERENCE: 

The verification¹⁶ plan should be a requirement of the verification operation of a particular product. A point-by-point plan of testing techniques which will be checked during the validation will be validated efficiently. The inspecting plan subsume examining aim, No. of tests & the frequent examining for all stage's activity is chosen rely on features of the item and important points of equipment. The quantity of tests ought to be satisfactory to give adequate measurable certainty of value both inside a batch and among them. Nature of test of samples relies on 1x – 3x formula.  According to USFDA inspecting size can be expanded from 1x – 10x gave on deductively legitimized. The acknowledgment models for all testing gotten from a specific pharmacopeia/laid particulars/foreordained acknowledgment rules and any place inspecting is accomplished for the scholastic interest for future of product life cycle. Sampling area is to be obviously demonstrated by chart for equipment from which the example is removed (any place application). This will be help validation group.  

 • When the wellspring of excipient is changed, with critical change in physical and compound boundaries.  

• One process validation batch with the excipient from the new source will be produced. 

Complete validation batch¹⁷ of one group according to singular interaction convention of that item will be followed. The verification test and the results obtained therein will be scrutinized through acknowledgment samples of the test or details and similar compliance will be discussed to facilitate verification. Recommendations for moves to be made in case of cut-off points, frequencies and limits are indicated in the report along with plans for operational controls that are essential for monitoring size and routine development. Further the general survey of results to be checked for consistency and reproducibility. Results ought to exhibit the control on the production all through all phases of assembling and the gathered information to demonstrate the consistency and reproducibility to yield a product which meets foreordained credits. In view of the outcomes produced during the investigation proceeded according to endorsed approval convention, an approval report will be readied.

8. FAILURE AND DEVIATION: 

 During testing any test will be examined¹⁸ to determine the occurrence of disappointment.   If the occurrence of disappointment is not self-evident, a selection technique may be valuable to us to guarantee that it covers all possible areas of potential failure.  Defects will be classified as: 

Type I: 

 For example, in the event of a failure to communicate, failure may be credited to an equipment failure raw material, which may be agreed to complete the approval process by adding another group to the failed group. This study and the resulting function will be remembered. 

Type II:  

Where the failure might be characteristic or where the examination is uncertain that the validation has fizzled. For this situation the validation terms choose and legitimize the efforts to be taken, recording its legitimization and exhortations. This choice will consider¹⁹:  

• Re-testing - if the outcomes of examination underpin the choice. 

• Introduction an adjustment in activity boundaries, process steps.  

• Changing the process equipment or the method for utilizing it. 

Suspension of the validation practice until additional specialized assessment as well as advancement has been completed.  

• Changing the testing system 

• Review of recorded information.  

• Change of the process validation acknowledgment measures.  

• Change to a method. 

9. THE REPORT OF VALIDATION²¹: 

A composed²⁰ report ought to be accessible after finishing the validation. Whenever accepted, it must be affirmed and approved (marked & dated). The report has to incorporate at any rate the accompanying:

1. Title and objective 

2. Reference to convention;  

3. Information of item;  

4. Equipment; 

5. Projects & cycles utilized;  

6. Subtleties of techniques & test strategies;  

7. Results (contrasted and acknowledgment standards); and  

8. Suggestions on the limits and standards to be applied on future.

10. APPLICATIONS OF VALIDATION²²: 

10.1. Depletion of quality cost: 

a)   Preventive expenses are costs brought about to avoid failures 

b) External failure costs associated with non-compliant conditions 

c) Estimated costs of inspection, testing and quality assessment. 

d) Internal failure costs

10.2. Process update: 

The development of facilities, equipment, etc. creates a quality product at a low cost.  Trained personnel are key components of optimization, because they improve production and efficiency. 

10.3. Assuring quality: 

PV & optimized process are key for affirming product's grades. Also, they are vital tools in GMP's without them acquiring quality is not possible. 

10.4 Safety: 

Calibrating working instruments and conditions by means of validation promote operation's safety. Since PV is elegantly standardized, they favour safety. 

10.5. Better consumer quality: 

Recalling from market deliberately cleaved by apparent validation improve consumer’s view towards the product's quality. PV is a systemic study that avoids recalling & any in appropriate outcomes from market. 

11. CONCLUSION: 

From all above things we can know the importance of validation. PV plays vital role in terms of maintaining quality product and process. There will be no compromise if all well follow validated procedures so high standard product will be produced constantly & reliably. An extensive disciplined validation assures product and process fill all fixed standards.QA measures are beneficial to assure standards in process. PV in pharma field is significant than any other field in terms of producing quality drug product, medical devices of patients not consumers. First of all, validation is vital & recognized constituted of cGMPs. Effective teachers can only make potent students just like what validation does to product. After the approval of drug, the pharmaceutical process validation affirms that each an every pre-determined standard will be acquired leading to precision of results. Not following the validation protocols cleaves our goal and entire process leads to defective product production and processing.

REFERENCES:

1. Guidance for Industry: Process Validation: General Principles and Practices. U.S. Department of Health and Human Services, Food and Drug Administration, Centre for Drug Evaluation and Research (CDER), Centre for Biologics Evaluation and Research (CBER), Centre for Veterinary Medicine (CVM), January 2011. 

2. Oechslein C, Lazar M. S – Process Validation from view report of the FDA, Maas & Peither AG – GMP Publishing, LOGFILE No. 3/ February 2012. 

3. Quality Management System – Process Validation Guidance GHTF/SG3/N99-10:2004 (Edition 2). 

4. Nash R. A and Wachter A. H, Pharmaceutical Process Validation an International Third Edition. Revised and expanded, Marcel Dekkar, Inc., New York, 2003; 17 – 40.  https://doi.org/10.1201/9780203912119

5. Patel R. C, Bhuva C. K, Singh R. P, Dadhich A, Sharma A., - Pharmaceutical Process Validation, Pharma tutor – ART – 1053. 

6. Kathiresan K*, Moorthi C, Prathyusha Y, Gade B. R, Reddy B. K, Manavalan R, An overview of pharmaceutical validation; Research Journal of Pharmaceutical, Biological and Chemical Sciences; 2010; 1(4):1026. 

7. Pharmaceutical Process Validation: Guide to Inspections of Oral Solid Dosage Forms pre/post Approval Issue for Development and Validation; issue (1/94); January, 2010.M8.

8. Green JM. A Practical Guide to Analytical Method Validation, Anal. Chem. News and Features 1996; 60:305A-9A. https://doi.org/10.1021/ac961912f

9.   Akers, J. Simplifying and improving process validation. J. Parent. Sci. Technol. 1993, 47, 281–284.

10. Avallone, H.L.; D‟Eramo, P. Scale-up and validation of ANDA/NDA products. Pharm. Eng.1992, 12 (6):36–39.

11. Chowhan, Z.T. Development of a new drug substance into a compact tablet. Pharm. Technol.1992, 16 (9):58–67.

12. Nash RA. Process Validation of a 17-Year retrospective study of solid dosage forms Drug DevInd Pharm 1966; 22 (1):25-34. https://doi.org/10.3109/03639049609043869

13. Therapeutics Products Programme. Process Validation: Aseptic Processes for Pharmaceuticals. http://www.hc-sc.gc.ca/hpbdgps/therapeutic; downloaded March 30, 2001.

14. Lambert J. Validation Guidelines for Pharmaceutical Dosage Forms. Health Canada / Health Products and Food Branch Inspectorate; 2004. pp. 7-15.

15. Gupta GD, Garg R, Aggarwal S. Guidelines on General Principles of Validation: Solid, Liquid and Sterile dosage forms. Pharm Sci Tech, 2008; 6:28-33

16. Dashora K, Singh D, Saraf S. Validation – the Essential Quality Assurance Tool for Pharma Industries. Pharminfo, 2005; 3:45-47.

17. FDA Guidance Update: process Validation: General Principles and Practices; version 01; 2009.

18. Validation Master Plan Installation and Operational Qualification – Pharmaceutical Inspection Convention; Pharmaceutical Inspection Co-Operation Scheme; PI 006 – 2; July, 2004.

19. Kiffer,R.G, J. Pharma. sic. tec., 1995, 44, 5, p.249.

20. Kumar NL, MoorthyDG, Kumar RS, Sekaran CS. An overview of pharmaceutical validation: quality assurance view point, 2011; 1(4):1003-1014. 

21. Agalloco J. The validation life cycle. J ParenterSci Technol. 1993; 47(3):142-147.

22. Sharp JR. The Problems of Process Validation. Pharm J 1986; 1:43-5.